| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-10 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-10 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-09 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-08 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-08 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-07 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |